Windward Bio is a clinical-stage drug development company focused on creating treatments for severe respiratory conditions, including asthma and COPD, using long-acting monoclonal antibodies and bispecifics.

Avenzo Therapeutics is a biotechnology company developing oncology therapies, including a CDK2 inhibitor for advanced solid tumors and HR+/HER2-negative metastatic breast cancer.

Adcentrx Therapeutics is a biotech company developing next-generation Antibody-Drug Conjugate (ADC) therapies for cancer, utilizing its proprietary i-Conjugation™ technology.